Is As­traZeneca look­ing for the ide­al can­di­date to re­place Pas­cal So­ri­ot?

You can ex­pect to hear plen­ty of new ru­mors about Pas­cal So­ri­ot’s im­pend­ing de­par­ture from As­traZeneca’s helm — whether they’re true or not.

A year af­ter So­ri­ot rather slow­ly re­fut­ed a host of press re­ports that he was con­sid­er­ing a jump to the helm at Te­va, The Sun­day Times re­port­ed over the week­end that As­traZeneca has be­gun suc­ces­sion plan­ning fol­low­ing share­hold­er pres­sure as the phar­ma gi­ant works to achieve a turn­around. They’ll al­so re­port­ed­ly be look­ing for some­one to suc­ceed chief fi­nan­cial of­fi­cer Marc Dunoy­er as well.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.